Announcements Trials
Browse Landscape

Phase

Phase 4 4Phase NA 1Phase EARLY_PHASE1 1Phase 1 1

Status

Completed 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Carcinoma, Hepatocellular 3Liver Neoplasms 2Colorectal Neoplasms 1

Interventions

Dexamethasone 49Metformin 47Cyclophosphamide 42Saline Solution 38Cytarabine 34Sodium Chloride 32Bupivacaine 31Vincristine 27Cisplatin 26Propofol 25Methotrexate 25Letrozole 24Fluorouracil 24Dexmedetomidine 24Doxorubicin 23Fentanyl 22Carboplatin 22Etoposide 19Rituximab 18Morphine 18Bevacizumab 18Acetaminophen 18Lidocaine 17Granulocyte Colony-Stimulating Factor 17Prednisone 16Mercaptopurine 16Docetaxel 16Clomiphene 16Sevoflurane 15Ropivacaine 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × OTHER × gadolinium ethoxybenzyl DTPA × Clear all
NCT04973007 2026-04-22

Comparison of Contrast Agents in Liver Magnetic Resonance (MR) for the Detection of Hepatic Metastases

University of Colorado, Denver

Phase 4 Terminated
10 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT04288323 2026-02-12

Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis

University of California, San Diego

Phase 4 Completed
79 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT03215355 2021-01-27

Improving CBCT for Liver IG-SBRT Using Gadoxetate Disodium

Nova Scotia Health Authority

Phase 4 Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01575574 2016-08-23

PRIGA

Fundacion Clinic per a la Recerca Biomédica

Phase 4 Completed
74 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡